Navigation Links
Miriam researcher helps develop global hepatitis C recommendations for injection-drug users
Date:7/25/2013

(PROVIDENCE, R.I.) A Miriam Hospital researcher has joined forces with international colleagues to call for new strategies to better manage and improve assessment and treatment for hepatitis C (HCV) infection in individuals who inject drugs.

Lynn E. Taylor, M.D., an HIV specialist focusing on HIV and viral hepatitis coinfection at The Miriam Hospital, was the only American physician invited to join the expert international panel that issued these first-of-its-kind recommendations. They were published online yesterday by the journal Clinical Infectious Diseases, just ahead of World Hepatitis Day on July 28.

The recommendations are part of a supplement entitled "Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward," developed in collaboration with the International Network on Hepatitis Care in Substance Users.

"In well-resourced parts of the world, most hepatitis C exists among people who currently inject drugs and those who have injected drugs in the past. However, treatment access and uptake among this population remains low even though we increasingly have effective treatments for hepatitis C, which is a curable disease," said Taylor.

"Research supporting our recommendations the first international set ever released for treating hepatitis C in people who inject drugs demonstrates that treatment can be successful when barriers to care are addressed within a supportive environment," she added. "In fact, the burden of liver disease worldwide could be dramatically reduced by increasing treatment for hepatitis C infection among people who inject drugs, by preventing forward transmission."

An estimated five million people in the U.S. have chronic HCV infection, a liver disease that may result in long-term health problems, including liver scarring, liver failure and liver cancer. According to the Centers for Disease Control and Prevention, approxima
'/>"/>

Contact: Jessica Collins Grimes
jgrimes2@lifespan.org
Lifespan
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Miriam study reveals financial benefits of a plant-based, Mediterranean diet
2. Miriam researchers urge physicians to ask younger men about erectile dysfunction symptoms
3. Researchers find potential new target to treat malignant pleural mesothelioma
4. Air Conditioning Can Dehydrate Skin and Eyes Reports Water and Health Researcher Sharon Kleyne
5. Researchers target HER1 receptor for peptide cancer vaccine, therapeutic agents
6. University Researcher, International Assistance Dog Week Founder Announce Partnership to Increase Employment for People with Disabilities Partnered with Assistance Dogs
7. Researcher develops peer-led program to help individuals with HIV adhere to treatment plans
8. University of Hawaii Cancer Center researchers report
9. Mount Sinai researchers discover mechanism behind development of autoimmune hepatitis
10. Dead gene comes to life, puts chill on inflammation, Stanford researchers find
11. Researchers identify 146 contemporary medical practices offering no net benefits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... 2014 TASC (Total Administrative Services ... benefits account management services, announces the release of ... on taxes, reduce administrative workload, and lessen liability. ... and the efficient handling of complex, time-sensitive, and ... best meets their goals and objectives. The four ...
(Date:10/25/2014)... 2014 The federal judge overseeing ... ) filed against Boston Scientific Corp. in the ... Southern District of West Virginia has denied a ... in a group of cases filed on behalf ... October 21st, U.S. District Judge Joseph R. Goodwin ...
(Date:10/25/2014)... (HealthDay News) -- Not getting the right amount of ... new study suggests. Those who sleep less or ... night may be more prone to developing the chronic ... The study authors concluded that duration and quality of ... with inflammatory bowel diseases. "Both short and long ...
(Date:10/25/2014)... 24, 2014 (HealthDay News) -- October,s shorter, darker days ... affective disorder, according to an expert. People ... feel overly tired, lack motivation and even have trouble ... lead to suicide, said Dr. Angelos Halaris, a professor ... Loyola University Chicago Stitch School of Medicine. "Seasonal ...
(Date:10/22/2014)... Isabel Healthcare will participate ... (ASAHP) Conference on October 22-24 in Las Vegas, NV. ... a panel discussion on Technology in Health Professions Education ... a diagnostic decision support tool and clinical education platform ... students and clinical learners. The Isabel tools help clinicians ...
Breaking Medicine News(10 mins):Health News:TASC’s New Suites Offer Tax Savings and Protection 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Sleep Duration Linked to Ulcerative Colitis Risk in Study 2Health News:Dark Days Here for Folks With Seasonal Depression 2Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2
... ... ... Dozier Internet Law, P.C. has filed a lawsuit (Case No. CGC-10-499227) on behalf of ... San Francisco, against Yelp! Inc. The lawsuit alleges that Yelp! has been operating an ...
... Abstract 35P: Markers for risk of pregnancy-associated breast ... child-birth to the third and fourth decades, the ... rise. This paper suggests that identification of p53 ... outbreak or early detection of pregnancy-associated breast cancer. ...
... as epigenetic modifications, regulate the activity of many ... often inactivates important cellular growth brakes. Therefore, this ... major cause of uncontrolled division of cancer cells. ... methylation. Unlike changes in the blueprint ...
... one wants antibiotic residues in their milk. But antibiotics are ... conducted nowadays take hours to produce a result and do ... can now be closed, thanks to a fully automated minilab ... LMU Muenchen and gwk Praezisionstechnik GmbH. Even at ...
... had previous sprain, study says , FRIDAY, May 7 ... in female high school volleyball players, a new study ... players (59.3 percent female, 40.7 percent male) who wore ... and non-rigid) for an entire season and 42 who ...
... contraceptives altered the social and sexual landscape in ways expected ... millions of women have taken it at some point in ... have been arrested for it and it,s still one of ... it,s simply known as "the Pill." , On May 9, ...
Cached Medicine News:Health News:Yelp! Sued Over Alleged Protection Racket 2Health News:Interesting stories at the IMPAKT Breast Cancer Conference 2Health News:Interesting stories at the IMPAKT Breast Cancer Conference 3Health News:Fatty acid to enhance anticancer drug 2Health News:Minilab can quickly identify antibiotic residues in milk, before it leaves the barn 2Health News:Minilab can quickly identify antibiotic residues in milk, before it leaves the barn 3Health News:Ankle Braces May Protect Girl Volleyball Players 2Health News:The Pill Turns 50 2Health News:The Pill Turns 50 3Health News:The Pill Turns 50 4Health News:The Pill Turns 50 5
(Date:10/22/2014)... 2014  Medical Diagnostic Laboratories, L.L.C., (MDL), ... high complexity, state-of-the-art, automated DNA-based molecular analyses, ... Cystic Fibrosis Testing which utilizes cutting edge ... Cystic fibrosis (CF), or mucoviscidosis, ... affects the respiratory, gastrointestinal and reproductive systems. ...
(Date:10/22/2014)... Oct. 22, 2014  Rescheduling of hydrocodone combination ... the pain market, according to a new primary ... firm providing market research and consultation exclusively in ... - http://photos.prnewswire.com/prnh/20141021/153440 In ... hydrocodone combination products from Schedule III to Schedule ...
(Date:10/22/2014)... -- Investor-Edge has initiated coverage on the ... ), Progenics Pharmaceuticals Inc. (NASDAQ: PGNX ), ... Pharmaceuticals Inc. (NASDAQ: IDRA ), and Merrimack ... companies can be accessed at: http://investor-edge.com/register . ... ended at 4,419.48, up 2.40%, the Dow Jones Industrial ...
Breaking Medicine Technology:Medical Diagnostic Laboratories, L.L.C. Institute for Biomarker Research Announces New Prenatal Cystic Fibrosis Tests 2Hydrocodone: Rescheduled, Repositioned & Reinvented 2Hydrocodone: Rescheduled, Repositioned & Reinvented 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 2Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 4Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 5
... Ureteral Stents have all the advantages ... addition, a unique 360 degree kidney ... placement in the renal pelvis or ... remarkably comfortable stent, ideal for use ...
All the advantages of Dr. Roy P. Finney's classic stent design with an open tip....
This EIA microplate opens new perspectives in the direct detection of Chlamydia. The choice of microplate immunoenzymatic technology and the use of a monoclonal antibody result in a combination of c...
Inquire...
Medicine Products: